TY - JOUR
T1 - Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: An initial assessment
AU - Butterfield, D.A.
AU - Gnjec, Anastazija
AU - Poon, H.F.
AU - Castegna, A.
AU - Pierce, W.M.
AU - Klien, J.B.
AU - Martins, Ralph
PY - 2006
Y1 - 2006
N2 - Objective: To identify oxidatively modified proteins in brains of persons with inherited Alzheimer's disease. Methods: Redox proteomics was used to identify oxidatively modified brain proteins in persons with mutations in the genes for presenilin-1 (PS-1). Results: An initial redox proteornics assessment of oxidatively modified proteins from brains of individuals with PS-1 mutations was performed. These PS-1 mutations, Q222H and M233T, are completely penetrant causing early-onset familial AD as, previously reported in these Australian families. We show that oxidative modifications of ubiquitin carboxyl-terminal hydrolase L1 (UCH-LI), gamma-enolase, actin, and dimethylarginine dimethylarninohydrolase 1 (DMDMAH-1) are present in the brain of familial AD subjects. Conclusions: These initial results suggest that oxidatively modified proteins are important common features in both familial and sporadic AD.
AB - Objective: To identify oxidatively modified proteins in brains of persons with inherited Alzheimer's disease. Methods: Redox proteomics was used to identify oxidatively modified brain proteins in persons with mutations in the genes for presenilin-1 (PS-1). Results: An initial redox proteornics assessment of oxidatively modified proteins from brains of individuals with PS-1 mutations was performed. These PS-1 mutations, Q222H and M233T, are completely penetrant causing early-onset familial AD as, previously reported in these Australian families. We show that oxidative modifications of ubiquitin carboxyl-terminal hydrolase L1 (UCH-LI), gamma-enolase, actin, and dimethylarginine dimethylarninohydrolase 1 (DMDMAH-1) are present in the brain of familial AD subjects. Conclusions: These initial results suggest that oxidatively modified proteins are important common features in both familial and sporadic AD.
M3 - Article
VL - 10
SP - 391
EP - 397
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
SN - 1387-2877
IS - 4
ER -